JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shirbacheh, M. V.
Right arrow Articles by Gruber, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shirbacheh, M. V.
Right arrow Articles by Gruber, S. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOSPORIN A

Vol. 289, Issue 3, 1185-1190, June 1999

Pharmacokinetic Advantage of Intra-arterial Cyclosporin A Delivery to Vascularly Isolated Rabbit Forelimb. I. Model Development1

Mansour V. Shirbacheh, Xiaoping Ren, Jon W. Jones, Warren C. Breidenbach, Anthony W. Jevans, G. Rafael Fernandez-Botran, Claudio Maldonado, John H. Barker and Scott A. Gruber

Divisions of Plastic and Reconstructive (M.V.S., X.R., C.M., J.H.B.), General (J.W.J.), and Hand and Microsurgery (W.C.B.), Department of Surgery, and the Department of Pathology (A.W.J.), University of Louisville School of Medicine, Louisville, Kentucky; the Department of Pathology (R.F.B), Jewish Hospital, Louisville, Kentucky; and the Division of Immunology and Organ Transplantation (S.A.G.), Department of Surgery, University of Texas at Houston Health Science Center, Houston, Texas

Effective antirejection therapy with minimal systemic morbidity is required if limb transplantation is to become a clinical reality. We investigated whether i.a. infusion of cyclosporin A (CSA) into the vascularly isolated rabbit forelimb will distribute drug homogeneously to the tissues and produce higher local drug levels than same-dose i.v. treatment, thereby improving the therapeutic index. CSA 4.0 mg/kg/day was infused continuously via osmotic minipump into either the right brachial artery (i.a. group) or jugular vein (i.v. group) of New Zealand rabbits. Ligation of all muscles at the right mid-arm level was performed in the i.a. group to eliminate collateral circulation and simulate allografting, while leaving bone and neurovasculature intact. On day 6, CSA concentrations were measured in skin, muscle, bone, and bone marrow samples taken from different compartments of the right and left forearms in the i.a. group and right forearm only in the i.v. group. There were no significant differences between compartmental CSA levels in all tissues examined on the locally treated, right side during i.a. infusion, indicating that drug streaming from the catheter tip is not occurring in our model. During i.a. infusion, mean CSA concentrations were 4- to 7-fold higher in the right limb than in the left limb in all four tissues examined. Tissue CSA levels in the left limb were equivalent to those achieved during i.v. infusion, but CSA concentrations in blood, kidney, and liver were higher during i.a. infusion. These favorable, preliminary, single-dose pharmacokinetic results warrant further investigation in our novel rabbit model.


0022-3565/99/2893-1185$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. V. Shirbacheh, T. A. Harralson, J. W. Jones, W. C. Breidenbach, A. W. Jevans, C. Maldonado, J. H. Barker, and S. A. Gruber
Pharmacokinetic Advantage of Intra-arterial Cyclosporin A Delivery to Vascularly Isolated Rabbit Forelimb. II. Dose Dependence
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1191 - 1195.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. V. Shirbacheh, J. W. Jones, T. A. Harralson, J. Edelstein, T. Tecimer, W. C. Breidenbach, A. W. Jevans, C. Maldonado, J. H. Barker, and S. A. Gruber
Pharmacokinetics of Intra-arterial Delivery of Tacrolimus to Vascularly Isolated Rabbit Forelimb
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1196 - 1201.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.